Abstract:In pharmaceutical research and development, various new chemical entities (NCE) are found to be poorly water-soluble. Therefore, solubility enhancement, a key factor for higher bioavailability, is a major challenge in pharmaceutical industries. Particle size reduction is one such method that increases the surface area of the pharmaceutical compounds and subsequently leads to a higher dissolution rate and bioavailability. Conventional processes such as milling, high-pressure homogenization, and spray drying are well established and widely used for particle size reduction. However, a few disadvantages such as a broader particle size distribution (PSD) and thermal and chemical degradation of the product are major concerns for the product quality. Non-conventional processes such as liquid anti-solvent crystallization, supercritical anti-solvent process, rapid expansion of supercritical solutions, particles from gas saturated solutions, and pulsed laser ablation are emerging as potential alternatives to overcome the disadvantages of conventional processes. This review critically summarizes the milling, spray drying, high-pressure homogenization, liquid anti-solvent crystallization, spray freeze-drying, supercritical carbon dioxide <span class="mathjax-tex">\((\mathrm{SC C}{\mathrm{O}}_{2})\)</span>–based micronization processes, pulsed laser ablation and combinative techniques. The success of these processes in enhancing the dissolution rate and bioavailability of many active pharmaceutical ingredients (APIs) has been critically examined. The advantages and limitations of these processes are also discussed. Finally, opportunities for future research are also proposed.

A Critical Review of Spray-Dried Amorphous Pharmaceuticals: Synthesis, Analysis and Application.

A critical review of spray-dried amorphous pharmaceuticals: Synthesis, analysis and application

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Recent progress on crystallizations of amorphous pharmaceutical solids

A meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle engineering approaches for pharmaceutical technologies

Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling

Enhancing Bioavailability of Natural Extracts for Nutritional Applications Through Dry Powder Inhalers (DPI) Spray Drying: Technological Advancements and Future Directions

Co-amorphous Systems for the Delivery of Poorly Water-Soluble Drugs: Recent Advances and an Update

Review of patents and application of spray drying in pharmaceutical, food and flavor industry

Advancements in spray drying, part II: From configuration to variegated applications in pharmaceuticals and chemical processing

Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches

Combining Co-Amorphous-Based Spray Drying With Inert Carriers To Achieve Improved Bioavailability And Excellent Downstream Manufacturability

A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals

Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels

Co-spray Drying Drugs with Aqueous Polymer Dispersions (APDs)—a Systematic Review

Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

Recent Advances in the Application of Characterization Techniques for Studying Physical Stability of Amorphous Pharmaceutical Solids

Particle Size Reduction Techniques of Pharmaceutical Compounds for the Enhancement of Their Dissolution Rate and Bioavailability

Amorphous systems for delivery of nutraceuticals: challenges opportunities

Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers

Advanced in Solubilization Methods of Water-Insoluble Natural Drugs